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Anti-inflammatory activityTropical ecosystems are particularly rich in edible plant species with different bioactive
substances. Among the plants with promising benefits for health are species from the
genus Dioscorea (Dioscoreaceae), especially those named yam. Recent studies have shown
the beneficial effects of different species of Dioscorea, and its main constituent, diosgenine,
in the treatment of food allergy. In this study we evaluated the potential of D. trifida, the
only yam native from South America, in the treatment of ovalbumin (OVA) induced food
allergy in Balb/c mice. HPLC/DAD analysis showed the presence of three very distinctive
groups of natural products in extracts and fractions: (I) very polar substances, including
allantoin, (II) phenolic substances as flavonoids and phenolic acids and (III) diosgenin
and derivatives. Sensitive mice received casein feed with supplementation of crude extract
(CE) and fractions. The supplementation with all products from D. trifida reduced IGE, intes-
tinal oedema andmucus production, parameters observed in OVA allergic mice. The results
showed the potential of this food to prevent or treat this disease and the necessity to be
better explored.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
The number of food allergy cases has increased over the last
few decades in both developed and developing countries.
There is no effective treatment for this condition and bioac-
tive substances, present in vegetable foods, are considered
to be an important alternative to management and/or treat-
ment. Tropical ecosystems are particularly rich in edible plant
species with different bioactive substances and constitute
one-third of the botanical biodiversity of the planet (Cardellina,
2002; Desmarchelier, 2010; Devalaraja, Jain, & Yadav, 2011;Oliveira, Yamada, Fagg, & Branda˜o, 2012). Among the foods
with promising benefits are species from the genus Dioscorea
(Dioscoreaceae), commonly named yam.
The tubercles of the yam have been used in the human
diet for centuries. Many species have economic importance,
due the presence of diosgenin, which is used as a prototype
for oral contraceptive in the pharmaceutical development
(Hata, Reguero, Garcia, Buitrago, & Alvarez, 2003). The most
important species cultivated for their edible tubers include
D. alata, originating from Asia, D. cayenensis and D. rotundata
from West Africa, and D. trifida from tropical America. The
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carbohydrates, amino acids, minerals, tiamine, riboflavin,
niacine and ascorbic acid. Diosgenin and allantoin constitute
the mainly secondary bioactive metabolites (Huang, Ku, &
Jan, 2009; Yang, Lu, & Hwang, 2003), and have also been
shown to possess anti-inflammatory and immunomodulatory
properties (Lin & Yang, 2008; Jan, Wey, Kuan, Liau, &Wu, 2007;
Lin, 2006; Macpherson & Uhr, 2004). Recent studies showed
that Dioscorea, and its main constituent, diosgenine, are use-
ful for the treatment of food allergies. Diosgenine reduced
IgE and IL-4 production and increased IFN-a levels (Huang,
Liu, & Jan, 2010; Huang et al., 2009). In vitro immunomodula-
tory activity was as well attributed to the alkaloid dioscorine
(Liu, Shang, Wang, Hsu, & Hou, 2007), which also promoted
the activation of macrophages, NK cells and increased pro-
duction of IFN-a in vivo (Liu, Liu, Huang, Wang, & Shang,
2009). D. batatas (syn. D. opposita) is a well-studied species
and exhibits antioxidant (Hou et al., 2001; Yang, Yoon, Chin,
Park, & Kim, 2009) and immunomodulatory activities (Choi,
Koo, & Hwang, 2004), and inhibits the enzyme nitric oxide
synthase (NOS) (Jin et al., 2010; Yang et al., 2009).
Different species of yam (‘‘inhame’’ in Portuguese) are cul-
tivated and used as food in Brazil, but only D. trifida is native
to South America. This species is cultivated in the northern
region of the continent and in the Caribbean. It produces a
group of small tubers that are 15–20 cm long. The flesh can
be white, yellow, pink or purple (Purseglove, 1972). Nothing
is known about the chemical composition and biological po-
tential of this species. Therefore, we evaluated the activity
of extracts and fractions obtained from the tubercles of D. tri-
fida in the treatment of OVA-induced food allergy in Balb/c
mice, and discuss about the participation of the detected bio-
active compounds in its activity.
2. Materials and methods
2.1. Plant material
Tubercles of D. trifida L.f. were acquired from producers in Boa
Vista, Roraima, in north of Brazil, in October of 2009. The sam-
ples were identified by J. Paula-Souza, and a voucher was
deposited in DATAPLAMT, from UFMG (number DAT-125).
2.2. Extract and fractions preparation
Dried and pulverized tubercles were extracted by percolation
with ethanol (80%) and the solution was evaporated in vac-
uum until dryness resulting in the crude extract (CE). The
CE was diluted in water and extracted successively with
dichloromethane and butanol saturated with water which re-
sulted in two fractions. These fractions were evaporated to
dryness to obtain dichloromethane (DF) and butanol fraction
(BF) fractions, respectively. An aqueous fraction (AF) was ob-
tained by freeze drying. The objective of this process was to
obtain products enriched in substances of different polarities.
2.3. Chromatographic analysis of the CE and fractions
The CE and the fractions (DF, BF and AF) were analysed by
high performance liquid chromatography (HPLC), using anAgilent 1100 with a DAD UV detector. The column used
was a Lichrospher C18 (250 um, 4.6 mm, Merck, Darmstadt,
Germany) at 30oC, acetonitrile (A): water (B) as mobile phase;
gradient elution at 35–100% A for 0–45 min and then at 100%
A for 45–50 min. Rebalancing: 100–35% A for 50–55 min, and
then 35% A for 55 a 60 min; flow of 1 mL/min. The presence
of allantoin and diosgenin in all products was confirmed by
the co-analysis with reference standard of these substances
(Sigma–Aldrich, St-Louis, MO, USA). The other substances
were identified by analysis of their respective UV spectra at
205 nm. The standards were prepared in acetonitrile/water
(1:1) at concentration of 0.5 mg/mL and the products from
D. trifida at 6 mg/mL. The volume of injection was 40 lL.
The quantification of the substances was done by calcula-
tion of the area of each peak in the chromatograms.
2.4. Animals
Groups of five female BALB/c mice with weigh between 18 and
20 g, aged 6–8 weeks, were fed a balanced feed diet (casein
diet, ANI93G) prepared in the laboratory. The animals were
kept in 12/12 h light/dark rhythm and controlled temperature
with free access to water and feed in cages with five animals
each. The studies were approved by the Ethics Committee for
Animal Experimentation at UFMG (CETEA/UFMG, number
010/2010).
2.5. Sensitisation of the mice
On day 0, the mice received a subcutaneous injection of
0.2 ml saline containing 10 lg Ova (five times crystallised
hen’s egg albumin; Sigma–Aldrich, St. Louis, MO, USA) and
1 mg Al(OH)3, as previously described (Saldanha et al.,
2004). A second subcutaneous injection of 10 lg soluble
Ova was given on day 14. Seven days later (day 21), the ani-
mals were given a solution of Ova 20% administered in the
drinking water for a period of 1 week (day 21–28). The non-
sensitised group received in the subcutaneous injection
only the adjuvant diluted in saline on day 0 and saline on
day 14.
2.6. Doses and treatment
The CE and the fractions were added as supplement to the
casein diet. CE was added at doses of 100 and 300 mg/kg/
day (CE100 and CE300) and AF, BF and DF at 100 mg/kg/day.
The control animals (non-treated, NT) received only casein
feed without supplementation, and the positive control re-
ceived casein feed supplemented with dexamethasone (DX-
Decadron) at a dose of 0.4 mg/kg/day (Cara, Conde, & Vaz,
1997). The final dose of substances administered to the ani-
mals was calculated by weighting the feed before the con-
sumption and after the consumption of each group every
day during the 28 days of experiment.
2.7. Body weight evaluation
Body weight was measured each week, and the results were
obtained by calculating the means of the individual values
of each group, expressed in grams (g).
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Serum samples used for anti-Ova IgE quantification were ob-
tained from the animal groups sacrificed by cervical disloca-
tion 7 days after oral antigen exposure. Anti-Ova IgE was
measured by capture-ELISA using plates coated with rat
anti-mouse IgE, as previously described (Russo et al., 2001).
The plates were developed with o-phenylenediamine and
H2O2 and were read at 492 nm on an automated ELISA reader
(EL800, Bio-Tek Instruments, Inc., Winooski, VT, USA). The
data are reported as the mean ± SEM for each group. The ser-
um IgE samples were compared to a positive control serum,
which was taken as 1000 arbitrary units (A.U.). Five animals
were included in each group. P < 0.05 was considered statisti-
cally significant.
2.9. Intestinal tissue water content
Duodenum fragments (1 cm) were collected and weighed. The
samples were dried at 60 C for 24 h, and the dry weight was
determined by the following formula: water content = (wet
weight  dry weight)/dry weight. The data are reported as
the mean ± SEM of each group, which was calculated using
the following formula: water content = (wet weight  dry
weight)/dry weight. Five animals were included in each group.
P < 0.05 was considered statistically significant.
2.10. Histological analysis
The histological analysis was performed as previously de-
scribed (Saldanha et al., 2004). Tissue samples were fixed in
10% formalin in PBS, embedded in paraffin and cut into 5-
lm-thick sections. The sections were stained with periodic
acid Schiff (PAS) for mucus analysis or with toluidine blue
to evaluate the number of mast cells.
2.11. Mast cells evaluation
Histological sections stained with toluidine blue, and used to
count mast cells were examined under an optical microscope.
The count was conducted in 20 randomly selected fields
observing at 40· (53.333 lm2/field) and the result expressed
as number of cells/field.
2.12. Evaluation of mucus containing neutral mucin
After staining for histological analysis, a microcamera was
used to capture images of three fields in each small intestine
section. The images were analysed using Image J software. To
determine the caliciform cell volume, all green pixels were se-
lected to create a binarised image and subsequently calculate
the total area. The results were expressed in lm2 P.A.S./Field.
2.13. Eosinophil peroxidase assay
A colorimetric assay for peroxidase was performed using the
method described by Silveira et al. (2002). The eosinophil per-
oxidase (EPO) assay was used as an estimate of eosinophil
numbers in intestinal tissue. After flushing the small intes-tine with 20 ml of PBS, 100 mg of the intestinal tissue was
weighed, chopped, and homogenised in PBS 5% (w/v) by using
a tissue homogenizer (Power Gen 125; Fisher Scientific, Pitts-
burgh, PA, USA). The homogenate was centrifuged (3000g for
10 min), the red blood cells in the pellet were lysed, and cells
were resuspended in PBS (pH 7.4) containing 0.5% hexadecyl
trimethyl ammonium bromide (HTAB; Sigma–Aldrich, St.
Louis, MO, USA). The cell solution was homogenised again,
and the homogenates were then subjected to freeze/thaw
three times in liquid nitrogen and were stored at 20 C until
the assay execution. Then, samples of the intestinal tissue
were spun down and supernatant was diluted 1:3 in PBS/
HTAB. The assay was carried out in 96-well plates (Nalge
Nunc International Co., Naperville, IL, USA). Each sample
was tested in triplicate by adding 100 ll of the sample/well
and 100 ll of OPD substrate (1.5 mM o-phenylalanine-diamine
(Sigma–Aldrich, St. Louis, MO, USA) and 6.6 mM hydrogen
peroxide in 75 mM Tris–HCl, pH 8.0)/well. The reaction was
carried out at 20 C for 30 min and was stopped with 4 M sul-
phuric acid solution. Plates were read at 492 nm on a micro-
plate reader (Tittertek Multiskan). The data are reported as
the mean ± SEM for each group, and the results expressed in
arbitrary units (A.U.), n = 5 animals/group. P < 0.05 was con-
sidered statistically significant.
2.14. Periuterin fat, spleen and liver weight evaluation
This analysis was performed to verify whether the loss of
body weight was obscured by fluid retention. The periuterin
fat, spleen and liver from the mice in each group were col-
lected and weighted to evaluate whether there was any water
retention that could interfere with the body weight
measurements.
2.15. Statistical analysis
Statistical significance was analysed using a one-way analysis
of variance (ANOVA) followed by a Tukey test. Five animals
were included in each group. P < 0.05 was considered statisti-
cally significant. The data are reported as the mean ± SEM.
*P < 0.05 with respect to the control (Ova) groups. **P < 0.05
compared to the non-treated (NT) allergic (Ova+) group.
3. Results
3.1. Chemical analysis
The analysis of CE by HPLC showed the presence of three very
distinctive groups of natural products (Fig. 1a): (I) very polar
substances, with retention time (Rt) from 0 to 10 min, includ-
ing allantoin (Rt 2.14 min, Fig. 1b); (II) a group of phenolic sub-
stances, with Rt between 11 and 30 min, among them organic
acids and flavonoids and (III) unpolar substances with Rt from
31 to 60 min, constituted by diosgenin (Rt 51.09 min, Fig. 1b)
and its derivatives.
The chromatograms and UV spectra of AF, BF and DF
showed that these fractions are each one enriched in the dif-
ferent types of substances, which were separated from CE by
their polarity. AF is rich in substances with high polarity
Fig. 1a – Route of obtention of crude extract (CE) and fractions (AF, BF, DF) from D. trifida roots, and corresponding
chromatograms in HPLC/ DAD. Retention times: (I) Rt 0–10 min: very polar substances, allantoin at Rt 2.14 min; (II) Rt 11–
30 min: phenolic substances (organic acids and flavonoids) and (III) Rt 31–60 min: unpolar substances, diosgenin at Rt
51.09 min. Concentrations of each class of substances are between [ ].
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Fig. 1b – Chemical structure of the active components
diosgenin and allantoin.
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rich in diosgenin and derivatives and does not have polar sub-
stances. The quantitative results were: CE = 36.6% of sub-
stances from group (I), 60.6% from (II) and 3.0% from (III);
AF = 80.7% of (I), 19.3% of (II) and 0% of (III); BF = 9.0% of (I)and 90.7% of (II) and 0% of (III); DF = 0% of (I), 98.8% of (II)
and 1.2% of (III).
3.2. Consumption of a casein diet and body weight loss
After oral challenge with Ova, allergic mice lost approxi-
mately 8% of their body weight (data not shown). The treat-
ments did not affect body weight in the non-sensitised
groups. In the allergic groups, only DX treatment was able
to prevent weight loss.
3.3. CE and fractions reduce anti-Ova IgE in the serum of
allergic mice
Sensitisation induced the production of anti-Ova IgE in mice.
Fig. 2 shows that treatment with CE (CE100, CE300) and AF, BF,
DF or DX reduced anti-Ova IgE compared with non-treated
(NT) allergic mice (P < 0.05).
3.4. CE and fractions reduce intestinal oedema
The change in intestinal oedema in the allergic animals com-
pared to that of the non-treated (NT) allergic mice (P < 0.05)
was of 23% for CE100, 24% for CE300, 31% for AF, 32%
for BF, and 30% for DF (Fig. 3).
3.5. CE and fractions reduce mast cell hyperplasia
All of the treatments reduced the hyperplasia of mast cells in
allergic animals in comparison to non-treated (NT) allergic
Fig. 2 – Effects of the CE (A) and fractions (B) of D. trifida on the serum concentration of anti-Ova IgE of mice sensitised and
non-sensitised with OVA. Data are presented as mean ± SD (n = 5). *P < 0.05 with respect to their respective control (Ova)
groups. **P < 0.05 compared to the non-treated (NT) allergic (Ova+) group. NT, non-treated group; CE, animals that receive the
crude extract of D. trifida; CE100, animals treated with 100 mg/kg/day of the crude extract; CE300 animals treated with
300 mg/kg/day of the CE; DX, animals treated with dexamethasone; AF, animals treated with 100mg/kg/day of the aqueous
fraction; BF, animals treated with 100 mg/kg/day of the buthanol fraction; DF, animals treated with 100 mg/kg/day of the
diclorometane fraction.
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in the intestinal submucosa increased (P < 0.05) when com-
pared to the respective control group. The number of mast
cells in allergic animals treated with CE (CE100, CE300), AF,
BF and DF decreased when compared to NT animals of the
allergic group (P < 0.05) (Fig. 4).
3.6. CE and fractions decreased mucus secretion
Mucus secretion was reduced by 33% for CE100, 31% for
CE300, 22% for AF, 20% for BF, 31% for DF, and 38% for DX in
comparison with non-treated (NT) allergic mice (P < 0.05)
(Fig. 5).
3.7. CE and fractions decrease eosinophil peroxidase
All treatments were able to decrease eosinophil infiltration in
treated animals compared to NT animals (P < 0.05) (Fig. 6).
3.8. CE and fractions do not modify periuterine fat, liver
and spleen weight
No difference was observed (P < 0.05) in the liver, periuterine
fat and spleen weight for any of the treated animals. OnlyFig. 3 – Effects of the CE (A) and fractions (B) of D. trifida on intesti
Data are presented as mean ± SD (n = 5). *P < 0.05 with respect to
the non-treated (NT) allergic (Ova+) group. The groups are descrthe animals treated with the positive control DX showed a
significant decrease (P < 0.05) when compared to NT animals
(data not shown).
4. Discussion
The clinical symptoms of food allergy are characterised by a
set of immune reactions, including the secretion of cytokines
IL-4 and IL-13, which are associated with IgE production (Dou-
rado et al., 2010; Sampson & Wang, 2009). When Ova-sensi-
tised BALB/c mice are given an Ova solution as the only
liquid option, they develop local signs of inflammation that
are characterised by eosinophil infiltration, oedema, an in-
crease in number of mast cells in the intestinal submucosa,
mucus secretion, an increase in serum anti-OVA IgG1 and
IgE, andweight loss (Dourado et al., 2011). Recent studies have
demonstrated that many vegetal foods can exert beneficial ef-
fects on immunopathologies such as food allergy (Costa, Gar-
cia-Diaz, Jimenez, & Silva, 2013; Shen, Hsu, Lee, Chang, & Wu,
2012; Tantoush et al., 2012; Zhang, Yang, Rupa, Jiang, & Minea,
2012). These activities are correlated to different classes of
natural bioactive substances.
Firstly, it was necessary to determine which doses of the
extracts of D. trifida would be suitable for the study. It isnal oedema of mice sensitised and non-sensitisedwith OVA.
their respective control (Ova) groups. **P < 0.05 compared to
ibed in the legend to Fig. 2.
Fig. 4 – Effects of treatment with 100 and 300 mg/kg/day of the CE (A) and 100 mg/kg/day of AF, BF and DF (B) added to the
casein feed, from day 1 to day 28 on mast cell hyperplasia. Data are presented as mean ± SD (n = 5). *P < 0.05 with respect to
their respective control (Ova) groups. **P < 0.05 compared to the non-treated (NT) allergic (Ova+) group. The groups are
described in the legend to Fig. 2.
Fig. 5 – Effects of the CE (3.A) and fractions (3.B) of D. trifida on mucus production by caliciform cells of mice sensitised and
non-sensitised with OVA. And morfometric images for comparison of mucus production by caliciform cells between Ova+
and Ova in each group (3.C and 3.D). Data are presented as mean ± SD (n = 5). *P < 0.05 with respect to their respective control
(Ova) groups. **P < 0.05 compared to the non-treated (NT) allergic (Ova+) group. The groups are described in the legend to
Fig. 2.
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et al., 1989; Niu, Chen, Wu, Cheng, & Wen, 2010). Allantoin
(hydantoin 5-ureido) has been widely described in the litera-
ture as being responsible for numerous pharmacological
activities, including wound healing, anti-irritating, moisturis-ing, necrotic tissue remover, stimulating cell mitosis, as well
as stimulation of epithelial promoter, analgesic and keratolyt-
ic (Shestopalov et al., 2006; Veraldi, Menter, & Innocenti, 2008).
Due to these actions, allantoin has been used in medicinal
and cosmetic preparations over the past 70 years for different
Fig. 6 – Effects of the CE (A) and fractions (B) of D. trifida on eosinophyl peroxidase of mice sensitised and non-sensitized with
OVA. Data are presented as mean ± SD (n = 5). *P < 0.05 with respect to their respective control (Ova) groups. **P < 0.05
compared to the non-treated (NT) allergic (Ova+) group. The groups are described in the legend to Fig. 2.
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study of respiratory allergy, pure allantoin was used in doses
of 50 mg/kg/day and 25 mg/kg/day and it promoted suppres-
sive effects on allergic inflammation. In the two doses tested,
it caused a decrease in the number of eosinophils, in the pro-
duction of mucus by goblet cells in lung tissue and production
of IL-4, IL-5, anti-OVA IgE and total IgE (Lee et al., 2010). Other
bioactive compound found in wild yam is diosgenin, but a
previous study showed the absence of this substance in D. tri-
fida (Rozanski, 1972) . In studies with pure diosgenin, doses of
100 mg/kg/day and 200 mg/kg/day promoted a reduction of
intestinal inflammation, in the number of mast cells and IgE
production (Huang et al., 2009). This same research group
demonstrated that the use of diosgenin implicated in de-
crease of GATA-4 and IL-3 and increased production of IL-10,
as a result of attenuating Th2 immune responses (Huang
et al., 2010). In another study, which used a model of respira-
tory allergy and two doses of pure diosgenin (200 mg/kg/day
and 400 mg/kg/day) Jan et al. (2007) found only a tendency
of decrease in the production of total IgE and anti-OVA
(P > 0.05). Our chemical analysis of crude extract from D. trifi-
da (CE) shows that allantoin corresponds to 36.6%, a similar
percentage of the tested substance, while diosgenin and cor-
related substance are present only in very low concentration
(3.0%). According to these results and considering that crude
extracts and not purified isolated compounds were used, it
was determined that doses of crude extract of D. trifida should
be tested as 100 and 300 mg/kg/day (which corresponds to
36.6 and 109.8 mg/kg/day of allantoin, and 3.0 and 9.0 mg of
diosgenin correlated substances/kg/day, respectively). When
testing extracts, we are trying to mimic the effect of the inges-
tion of food and its role as a functional food. In crude extracts
there is a mixture of various bioactive substances in low con-
centrations. However, it has been well established that the
complex mixture of bioactive compounds in fruits and vege-
tables can provide health benefits through the combination
of additive and synergistic effects (Seeram, Adams, Hardy, &
Heber, 2004).
One of the parameters used to analyse the development of
allergic process is the dosage of isotype IgE antibodies. These
immunoglobulins attach their respective FceRI receptors to
the surface of mastocytes/basophils, and following allergen
exposure, inflammatory mediators are released to generate
the allergic symptoms. All the tested products from D. trifidainhibited IgE production compared to not treated animals,
and this activity is probably due to the presence of diosgenin
and/or allantoin and correlated substances, as shown in pre-
vious studies (Huang et al., 2009, 2010; Lee et al., 2010). Since
the reduction in IgE production regulates T cell differentia-
tion, it can be suggested that diosgenin and allantoin modu-
late the food allergy response (a typical immune response to
Th2). In our experiment, the inhibition tended to be higher
in AF and BF, which contains allantoin, as DF with diosgenin.
During an allergic reaction, mediators such as histamine
and TNF-a are released to promote vascular permeability
and local blood flow (Bingham & Austen, 2000). This reaction
causes the leakage of proteins (such as albumin) and liquid
into the interstitium, causing inflammatory oedema (Brasile-
iro-Filho, 2006; Guo, Li, Lin, Samee, & Khalid, 2009). In animals
treated with CE and its fractions, we observed a reduction in
oedema, which was also probably due to the presence of dios-
genin and allantoin. Huang et al. (2009) have shown that dios-
genin reduced the production of anti-OVA IgE and the
inflammatory infiltrate in allergic BALB/c mice intestines,
resulting in a reduction in oedema. Tewtrakul and Itharat
(2006, 2007) found that crude extracts of D. membranaceae
and D. birmania, which is rich in sapogenins, inhibited the
production of NO (possibly by inhibiting the iNOS) and TNF-
a, leading to a reduction in intestinal oedema. A study by
Olayemi and Ajaiyeoba (2007) has also associated the antie-
dematogenic activity of crude extract from D. esculenta to
the presence of sapogenins. In vivo studies have demon-
strated that oral administration of allantoin attenuates the
production of IgE, IL-4 and IL-5 (Lee et al., 2010); has an
anti-inflammatory effect and promotes healing (Olayemi &
Ajaiyeoba, 2007).
Mastocytes are highly specialised cells that are activated
when antigens create connections with IgE on specific mem-
brane receptors. Degranulation occurs in seconds, releasing a
series of pre-formed inflammatory mediators (Yu et al., 2001).
These processes lead to an immediate increase in local blood
flow and vascular permeability, causing oedema (Cara, Ebbert,
& Mccafferty, 2004). As showed in Fig. 3 and 4, allergic animals
treated with products from D. trifida had a reduced number of
mastocytes and oedema. Huang et al. (2009) observed a reduc-
tion in mastocyte infiltration and its degranulation in the TGI
of animals that were allergic to OVA when treated with dios-
genin; this reaction might explain the observed reduction in
1982 J O U R N A L O F F U N C T I O N A L F O O D S 5 ( 2 0 1 3 ) 1 9 7 5 –1 9 8 4mastocytes induced by CE and DF. The reduction observed for
AF and BF could also be due to the presence of allantoin, as
observed previously by Lee et al. (2010).
In the food allergy model used in this study, BALB/c mice
showed an increase in mucus production by the caliciform
cells in the small intestine (Saldanha et al., 2004). Hypersecre-
tion of mucus is a characteristic allergic response and is in-
duced by IL-4 and IL-3; mucus is released to protect the
intestinal cells by limiting the antigen absorption (Dourado
et al., 2010; Saldanha et al., 2004). Animals treated with CE
showed a reduction in production of mucus, and this result
was also observed for AF, BF and DF. Previous studies showed
that diosgenin and allantoin activities reduce mucus produc-
tion in animals allergic to OVA (Huang et al., 2009; Lee et al.,
2010). This finding can explain the results observed for D. tri-
fida. IL-4 is involved in the hyperplasia and hypertrophy of
caliciform cells (Blanchard et al., 2004; Dourado et al., 2010),
and diosgenin reduced its production (Huang et al., 2009).
Other substances, such as those found in the species of Dios-
corea, could also be involved in IL-4 reduction. Glycoproteins
from D. batatas (sin. D. opposita) also caused inhibition in IL-
4 production in vitro (Oh & Lim, 2009).
The presence of eosinophil peroxidase (EPO) indirectly re-
flects the infiltration of eosinophils into intestinal mucosa.
Animals treated with CE and its fractions showed a reduction
of EPO. This reduction was probably due the presence of
allantoin, since the fraction enriched in this substance
showed better results. Pure allantoin had a similar effect in
the respiratory allergy model, causing a reduction in the infil-
tration of inflammatory cells, including eosinophils (Lee et al.,
2010).
In this study, we showed that products obtained from
tubercles of D. trifida reduced all of the inflammatory param-
eters associated with food allergies in Ova-sensitised animals
and this activity is correlated with the presence of allantoin
and diosgenin correlated substances. The presence of both
substances and its derivatives in the tested products can ex-
plain the activity observed in our studies. Phenolics are
known for their antioxidant activity and ability to reduce
reactive oxygen and nitrogen species generated by inflamma-
tion (Hou et al., 2001; Yang et al., 2009). Chemical analysis also
showed the presence of phenolic compounds in all the tested
products, but they may not be responsible for the activity. De-
spite being present in very high concentrations in BF (90.7%)
and DF (98.8%), for example, the activity was the same as ob-
served for AF, in which the concentration is very low (19.3%).
We have recently shown that the induction of food allergy
in mice leads to adipose tissue inflammation and systemic
metabolic alterations that contribute to the weight loss (Dou-
rado et al., 2011). In the present experiment, there was no dif-
ference in consumption of feed between the animal groups,
but the animals treated with Ova lost a slight amount of
weight. This is a result of hyper-catabolism caused by the pro-
duction of inflammatory cytokines. There is a decrease in the
consumption of Ova solution related to immunological aver-
sion (Cara et al., 1997; Dourado et al., 2010). To evaluate
whether weight loss in allergic animals was obscured by
water retention, as occurs in C57/BL6 families in OVA sensiti-
sations studies (Moreira, 2006), we evaluated the weight of
periuterine fat, but no differences were found. Jan et al.,2007 also did not find differences in animals treated with
diosgenin at dosages of 200 mg/kg/day and 400 mg/kg/day
compared with NTanimals. Possible hepatic damage was also
evaluated by weighing the liver, but there was no increase in
weight and there were no morphologic alterations in any of
the treated animals.5. Conclusion
This study shows that D. trifida reduced inflammatory param-
eters associated with food allergies and has potential to pre-
vent and treat this disease. New studies are necessary,
however, to confirm the participation of each substance in
the observed activities.Acknowledgements
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